Renske Altena

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

J. Beyer, Peter Albers, Renske Altena et al. · Annals of Oncology · 2012 · 322 citations · Full text

Medicine, Oncology, Cancer Survivorship Care +10

Angiotensin II–Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer

Annelies H. Boekhout, Jourik A. Gietema, Bojana Milojkovic Kerklaan et al. · JAMA Oncology · 2016 · 199 citations · Full text

Medicine, Oncology, Pharmacology +17

Early development of the metabolic syndrome after chemotherapy for testicular cancer

De Haas, Renske Altena, H.M. Boezen et al. · Annals of Oncology · 2012 · 115 citations · Full text

Medicine, Endocrinology, Oncology +15

Long-term exposure to circulating platinum is associated with late effects of treatment in testicular cancer survivors

Hink Boer, Johannes H. Proost, Janine Nuver et al. · Annals of Oncology · 2015 · 81 citations · Full text

Medicine, Oncology, Pharmacokinetics +16